{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:02:01Z","timestamp":1761894121134,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.soc.2004.06.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T13:29:14Z","timestamp":1113830954000},"page":"621-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991\u20132003"],"prefix":"10.1016","volume":"13","author":[{"given":"Ross A.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.soc.2004.06.004_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1091-255X(00)80105-5","article-title":"Resected adenocarcinoma of the pancreas\u2013616 patients: results, outcomes, and prognostic indicators","volume":"4","author":"Sohn","year":"2000","journal-title":"Gastrointest Surg J"},{"issue":"5","key":"10.1016\/j.soc.2004.06.004_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000658-199305010-00002","article-title":"One hundred and forty-five consecutive pancreaticoduodenectomies without mortality","volume":"217","author":"Cameron","year":"1993","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2004.06.004_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","article-title":"Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes","volume":"226","author":"Yeo","year":"1997","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soc.2004.06.004_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000658-199506000-00011","article-title":"Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients","volume":"221","author":"Yeo","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2004.06.004_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00000658-199501000-00007","article-title":"Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?","volume":"221","author":"Nitecki","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2004.06.004_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.1985.01390320023003","article-title":"Pancreatic cancer\u2014adjuvant combined radiation and chemotherapy following curative resection","volume":"120","author":"Kalser","year":"1985","journal-title":"Arch Surg"},{"key":"10.1016\/j.soc.2004.06.004_bib7","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B","article-title":"Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer","volume":"59","author":"Gastrointestinal Tumor Study Group","year":"1987","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.soc.2004.06.004_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0039-6109(16)46737-X","article-title":"Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head","volume":"75","author":"Abrams","year":"1995","journal-title":"Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.soc.2004.06.004_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1053-4296(97)80028-8","article-title":"Radiation therapy and 5-fluorouracil in pancreatic cancer","volume":"7","author":"Chakravarthy","year":"1997","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.soc.2004.06.004_bib10","series-title":"Pancreatic cancer","first-page":"153","article-title":"Chemotherapy and radiation therapy in the adjuvant management of pancreatic cancer","author":"Abrams","year":"2001"},{"issue":"1","key":"10.1016\/j.soc.2004.06.004_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(98)00179-5","article-title":"Adjuvant therapy for pancreatic cancer: back to the future","volume":"42","author":"Regine","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2004.06.004_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(96)85023-1","article-title":"Early evaluation of abdominal\/hepatic irradiation and 5-fluorouracil\/leucovorin infusion after pancreaticoduodenectomy","volume":"35","author":"Carducci","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.soc.2004.06.004_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0360-3016(99)00107-8","article-title":"Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma. Survival results and observations regarding patterns of failure, radiotherapy dose, and CA19\u20139 levels","volume":"44","author":"Abrams","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2004.06.004_bib14","first-page":"107","article-title":"Continuous infusion 5-fluorouracil given with calcium leucovorin, dipyridamole and mitomycin-C in patients with advanced colorectal carcinoma","volume":"4","author":"Isacoff","year":"1994","journal-title":"J Infus Chemother"},{"issue":"2","key":"10.1016\/j.soc.2004.06.004_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1091-255X(98)80008-5","article-title":"Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole","volume":"2","author":"Todd","year":"1998","journal-title":"J Gastrointest Surg"},{"issue":"13","key":"10.1016\/j.soc.2004.06.004_bib16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1089\/hum.1998.9.13-1951","article-title":"A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma","volume":"9","author":"Jaffee","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.soc.2004.06.004_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.2001.19.1.145","article-title":"Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation","volume":"19","author":"Jaffee","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2004.06.004_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199705000-00018","article-title":"Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single institution experience","volume":"225","author":"Yeo","year":"1997","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2004.06.004_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0360-3016(00)00755-0","article-title":"Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival","volume":"48","author":"Chakravarthy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2Suppl","key":"10.1016\/j.soc.2004.06.004_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0360-3016(02)03231-5","article-title":"A multivariate model for identifying risk of early death after pancreaticoduodenectomy and adjuvant therapy for periampullary adenocarcinoma: importance for understanding post treatment outcomes","volume":"54","author":"Abrams","year":"2002","journal-title":"Int J Radiat Onco Biol Phys"},{"key":"10.1016\/j.soc.2004.06.004_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/1097-0142(197603)37:3<1519::AID-CNCR2820370340>3.0.CO;2-O","article-title":"Carcinoma of the pancreas: review of MGH experience from 1963\u20131973\u2014analysis of surgical failure and its implications for radiation therapy","volume":"37","author":"Tepper","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2004.06.004_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6","article-title":"Patterns of failure after curative resection of pancreatic carcinoma","volume":"66","author":"Griffin","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2004.06.004_bib23","first-page":"305","article-title":"Studies on fluorinated pyrimidines. II. Effects on transplanted tumors","volume":"18","author":"Heidelberger","year":"1958","journal-title":"Cancer Res"},{"key":"10.1016\/j.soc.2004.06.004_bib24","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4","article-title":"Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5- fluorouracil) and high dose radiation+5-fluorouracil. The Gastrointestinal Tumor Study Group","volume":"48","author":"Moertel","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2004.06.004_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jnci\/80.10.751","article-title":"Treatment of locally unresectable carcinoma of the pancreas: comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone","volume":"80","author":"Gastrointestinal Tumor Study Group","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soc.2004.06.004_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2004.06.004_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Prolongation of the disease free interval in surgically treated rectal carcinoma","volume":"312","author":"Gastrointestinal Tumor Study Group","year":"1985","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.soc.2004.06.004_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2004.06.004_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdf040","article-title":"Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group","volume":"13","author":"Bajetta","year":"2002","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.soc.2004.06.004_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199710023371402","article-title":"Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer","volume":"337","author":"Ragaz","year":"1997","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.soc.2004.06.004_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high risk premenopausal women with breast cancer who received chemotherapy","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"issue":"9165","key":"10.1016\/j.soc.2004.06.004_bib32","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2004.06.004_bib33","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta analysis","volume":"10","author":"Warde","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2004.06.004_bib34","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2004.06.004_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin's lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2004.06.004_bib36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","article-title":"Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial","volume":"358","author":"Neoptolemos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2004.06.004_bib37","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(01)06666-1","article-title":"Continuing controversy over adjuvant therapy of pancreatic cancer","volume":"358","author":"Abrams","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.soc.2004.06.004_bib38","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.soc.2004.06.004_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(05)80349-1","article-title":"Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater\u2014results of a controlled prospective, randomized multicenter study","volume":"29A","author":"Bakkevolo","year":"1993","journal-title":"Eur J Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320704000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320704000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:48:53Z","timestamp":1760960933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320704000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S1055320704000572"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2004.06.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991\u20132003","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2004.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}